OrbiMed’s Ardent Health ARDT Stock Holding History

OrbiMed’s Portfolio ARDT Stock Details ARDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-206,000	Closed	-$3.52M	–	130
2024 Q4	$3.52M	Hold	206,000	–	–	0.07%	93
2024 Q3	$3.79M	Buy	+206,000	New	+$3.64M	0.07%	102

Other funds holding ARDT

CTC

Chai Trust Company Chicago, Illinois $1.18B AUM 19.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OrbiMed's ARDT Position: Q1 2025 in Review

OrbiMed sold out of Ardent Health (ARDT) in Q1 2025, closing a stake of 206,000 shares — an estimated $3.52M sold.

OrbiMed first reported a position in ARDT in Q3 2024 and held it in 2 quarters. The position peaked at $3.79M in Q3 2024. 108 funds tracked by Wall St. Rank hold ARDT as of Q1 2025.

OrbiMed reported no remaining Ardent Health position as of Q1 2025 after selling out during the quarter.
OrbiMed sold 206,000 Ardent Health shares in Q1 2025, an estimated $3.52M.
OrbiMed first reported a position in Ardent Health in Q3 2024 and held it in 2 quarters.
OrbiMed's Ardent Health position peaked at $3.79M in Q3 2024.
108 funds tracked by Wall St. Rank held Ardent Health as of Q1 2025.

Based on OrbiMed's 13F filing for Q1 2025, filed 15 May 2025.